» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 526-550 of 1083 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Evaluation of the effect of corticosteroid use in improving patients with COVID-19 (...) . Participants/Inclusion and exclusion criteria: Covid-19 patients over 18 years of age, definitive case based on (...) severe pneumonia due to COVID-19 and inclusion criteria, information including vital signs, level of
IRCTID: IRCT20200611047727N3
Study aim: To determine the efficacy and safety of azithromycin in treatment of patients with confirmed covid-19 infection in zeiaeian Hospital, Tehran Design: Two arm parallel group randomised trial (...) typically involvement of lungs in HRCT or Spiral CT scanning that attributed to a covid-19 pneumonia
IRCTID: IRCT20200415047092N1
  1. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study
  2. Safety and efficacy of “Hydroxychloroquine + Azithromycin + Naproxen + Prednisolone” and “Hydroxychloroquine + Azithromycin + Naproxen” regimens in comparison with “Hydroxychloroquine + kaletra” on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study
  3. Evaluating efficacy and safety of hydroxychloroquine + lopinavir or atazanavir/ritonavir combination in patients with COVID-19
  4. Comparison of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen with Lopinavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19, A randomized, double-blind study
  5. Comparing the effectiveness of Lopinavir/Ritonavir/Hydroxychloroquine and Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine treatment regiments in moderate to severe COVID-19 patients
  6. Evaluation of Atazanavir/Ritonavir effect on COViD-19 patients treatment in comparison with Lopinavir / Ritonavir
  7. Evaluation of the efficacy and safety of Umifenovir in the treatment of hospitalized patients with covid-19: A randomized clinical trial
  8. Evaluting the therapeutic and adverse effects of Interferon beta 1-a subcutaneous administration in patients with novel Coronavirus (COVID-19)
  9. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19
  10. A randomized clinical trial study, comparison of the therapeutic effects of Ivermectin, Kaletra and Chloroquine with Kaletra and Chloroquine in the treatment of patients with coronavirus 2019 (COVID-19)
parallel groups, double-blind, randomized on 40 patients with Covid-19 delirium, which according to the (...) delirium caused by Covid-19 admitted to the ICU of Sabzevar Vasei Hospital. The study will be a double (...) . Participants/Inclusion and exclusion criteria: Patients with Covid-19 delirium over 18 years of age
IRCTID: IRCT20210425051075N2
Study aim: Assessment of the effect of Iranian medicine product, Nigle 7 capsule and black seed mixture , on the symptoms of patients with covid-19 (Coronavirus 19 disease) Design: This clinical trial (...) older with COVID-19, Ground glass view at low-dose CT scan, Consciously completed consent form completed
IRCTID: IRCT20160131026298N6
and interferon alpha 2A) on the prognosis of patients with COVID 19 Design: Randomized, Placebo (...) COVID- 19 who admitted in the ٍEmam Hasan hospital of Bojnord and Shariati hospital of Mashhad. Eligible (...) •Clinical diagnosis of COVD-19 exclusion criterion •History of allergy to human albumin or interferon
IRCTID: IRCT20161206031256N3
  1. Efficacy and safety evaluation of therapeutic regimen of lopinavir/ritonavir and interferon beta 1b in patients with COVID-19
  2. Evaluation of the efficacy of the triple combination of interferon beta-1B (IFN β-1b), chloroquine and Kaletra in the treatment and improvement of symptoms in patients with covid -19: Clinical trial.
  3. Evaluation of the efficacy and safety of Co-trimoxazole in patients with COVID-19: A randomized open-label clinical trial
  4. Randomzied trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care- Iranian SOLIDARITY multicentre trial
  5. Efficacy and safety of Interferon beta-1-a in the management of the outpatients with mild to moderate COVID-19: A preliminary study
  6. Efficacy of different methods of administeration of combination regiemn including dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19: a randomized controlled trial
  7. effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital
  8. Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients admitted in Peymanieh hospital of Jahrom in 2020
  9. Effect of probiotic and zinc supplementation separately and in combination on reducing the complication of influenza-like syndrome during therapy by beta-interferon in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial
  10. Evaluation of adalimumab effect on clinical symptoms including respiratory distress, oxygen saturation and lung involvement of patients with COVID-19
, Mashhad Participants/Inclusion and exclusion criteria: Covid-19 patient with acute respiratory infectious symptoms and severe lung involvement (Inclusion criteria) Covid-19 patient with mild respiratory infectious
IRCTID: IRCT20160809029275N1
  1. Clinical trial of efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia
  2. Investigation the adipose and placenta-derived mesenchymal stem cells effect on the respiratory distress syndrome in patients with COVID-19: a pilot study
  3. Human Placenta-Derived Mesenchymal Stem Cell Transplantation in Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19: Phase I Clinical Trial)
  4. Evaluation of the Safety and Efficiency of Mesenchymal Stem Cell Derived Exosomes in patients with ARDS of COVID-19; An interventional randomized double-blind controlled clinical trial: phase I and II
  5. Evaluation of the Safety and Efficiency of human Umbilical Cord Derived Mesenchymal Stem Cell Exosomes in patients with ARDS of COVID-19; An interventional randomized double-blind controlled clinical trial: phase I and II
  6. Clinical trial study of safety and efficacy assessment of human umbilical cord matrix mesenchymal stem cell infusion on the treatment of new coronavirus 2019 pneumonia in humans
  7. Assessment of safety, efficacy and effective dose determination of human umbilical cord Wharton’s jelly mesenchymal stem cell transplantation on treatment of COVID-19 (coronavirus) pneumonia and complications in humans
  8. Evaluation of umbilical cord-derived mesenchymal stem cells (UC-MSCs) transplantation efficacy in the treatment of ankylosing spondylitis (AS)
  9. Evaluation of the efficacy and safety of cord-derived mesenchymal stem cell transplantation in the treatment of COVID-19
  10. Safety evaluation of intra-discal transplantation of allogeneic clonal bone marrow derived mesenchymal stromal cells in patients with low back pain induced by degenerative disc disease: Interventional clinical trial, phase I
of patients with COVID-19 admitted in Rasoul Akram and firoozgar hospitals who are under treatment (...) akram and Firoozgar hospitals, covid-19 admission wards for conduct a randomized clinical trial (...) will be based on the use of common treatment protocols in patients with covid-19. In the intervention
IRCTID: IRCT20170809035597N2
empowerment model on the common delayed outcomes of patients with Covid-19 Design: The clinical trial has a (...) Participants/Inclusion and exclusion criteria: People with COVID 19 who have been admitted to hospital wards and have been diagnosed with COVID 19 through a positive PCR and CT Scan report. Willingness to
IRCTID: IRCT20221006056103N1
Study aim: To determine the safety and immunogenicity of COVID-19 recombinant RBD protein vaccine in a healthy population Design: Phase I, randomized, double-blind, parallel arms, placebo-control (...) consistent with COVID-19, history of close contact with COVID-19 patient in the last 14 days, abnormal
IRCTID: IRCT20210620051639N1
  1. A double-blind, randomized, placebo-controlled Phase II clinical trial to evaluate the immunogenicity and safety of covid-19 recombinant RBD protein vaccine (80 microgram) of Plasma Darman Sarve Sepid Co. in healthy population.
  2. A double-blinded, randomized, placebo-controlled Phase I Clinical trial to evaluate the safety and immunogenicity of COVID-19 inactivated vaccine (Shif-Pharmed) in a healthy population
  3. A double-blind, randomized, placebo-controlled Phase I Clinical trial to evaluate the safety and immunogenicity of COVID-19 inactivated vaccine (Shifa-Pharmed) in a healthy population aged 51-75 years
  4. Comparison of the tolerability, safety, and immunogenicity of Shifa-Pharmed COVID-19 inactivated vaccine (CovIran) and Sinopharm vaccine in the healthy population aged 12 to 18 years: a double-blind, randomized, active-controlled, Phase I-II clinical trial.
  5. A Clinical trial to evaluate the immunogenicity and safety of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of age
  6. A double-blind, randomized, placebo-controlled Phase II/III Clinical trial to evaluate the safety and efficacy of COVID-19 inactivated vaccine (Shifa-Pharmed) in a population aged 18 to 75 years
  7. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
  8. Phase I, Safety and Immunogenicity of Razi SARS-CoV-2 recombinant Spike protein vaccine (Razi Cov Pars), in healthy adults aged 18-55 years; parallel 4 arms design (adjuvant only and three vaccine doses of 5, 10, and 20 µg/200µl); a Randomised, double blind, clinical trial
  9. Safety and Immunogenicity of Razi Cov-2 recombinant Spike protein vaccine (RAZI Cov Pars) in healthy children and adolescents aged 5-17 years; single group, open label study
  10. Immunogenicity and safety of pastocovac vaccine as a booster dose in comparison with sinopharm and pastocovac Plus boosters in Iranian adults aged 18 to 80 who received 2 doses of Sinopharm vaccine: a parallel group clinical trial
Study aim: The effect of hemoperfusion in the treatment of patients with Covid-19 disease admitted (...) Hospital, Rasht, on critically ill patients with COVID-19 admitted to the ICU. Patients will enter the (...) the ICU with a clinical diagnosis of Covid-19 with a respiratory rate≥ 30,heart rate≥125,oxygen
IRCTID: IRCT20110425006280N12
, lymphocyte count), renal (Cr, Urea) and liver (AST, ALT) in patients with COVID-19 before and after IVIg treatment Design: In this study, we first reviewed the records of patients admitted with COVID-19 and (...) : Inclusion criteria: Having laboratory and clinical results of COVID-19 2. Positive PCR test for COVID-19 3
IRCTID: IRCT20220213054013N1
blinded) Participants/Inclusion and exclusion criteria: All COVID-19 patients admitted to Shahid (...) for COVID-19 patients with Famotidine is prescribed. In group B, patients receive standard COVID-19 (...) Study aim: This study aims to investigate the effect of Famotidine on the recovery process of COVID
IRCTID: IRCT20200509047364N2
paraclinical symptoms in hospitalized patients with COVID-19 Design: A randomized controlled, triple blinded (...) controlled triple blinded trial that will be conducted on COVID-19 patients who referred to 29 Bahman (...) years and older with COVID-19 who had newly hospitalized; Having a definite disease; Having a signed
IRCTID: IRCT20200518047497N2
Study aim: The present study was conducted with the aim of the effectiveness of existential therapy on pathological worry and death anxiety of nurses who experienced sorrow due to the covid-19 pandemic (...) city Participants/Inclusion and exclusion criteria: Nurses who experienced the covid pandemic
IRCTID: IRCT20240217061040N1
  1. The Efficacy and Effectiveness of Schema Therapy in the Treatment of Women's Generalized Anxiety Disorder
  2. Comparing the Effectiveness of Acceptance-Based Behavior Therapy and Applied Relaxation in the Treatment of female with Generalized Anxiety Disorder
  3. Evaluation of the effectiveness of logotherapy based on Rumi’s thoughts on the anxiety, depression, and distress of frontline nurses during the COVID-19 epidemic
  4. Evaluation of the effectiveness of online mindful self-compassion training on the psychological symptoms associated with the Covid-19 pandemic in individuals with a history of Covid-19 infection themselves or family members
  5. The Effectiveness of Acceptance and Commitment-Based Therapy on Corona Anxiety and Resilience in Bodybuilding Athletes
  6. The Effect of group hypnotherapy on anxiety in women with Generalized Anxiety Disorder
  7. Comparison of the Effectiveness of Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy (CBT) on Depression and anxiety symptoms, Emotion Regulation Deficits, Perseverative Negative Thinking
  8. Looking at infertility treatment through the lens of spirituality:the impact of spiritual group psychotherapy on infertile women
  9. The effectiveness of emotional schema therapy and acceptance and commitment based on compassion on death anxiety, anger rumination and perfectionism in nurses with obsessive personality traits working in the Corona ward.
  10. Comparison of the Effectiveness of compassion therapy and eye movement desensitization and reprocessing therapy (EMDR) on coronary anxiety, uncertainty intolerance, catastrophizing and coping efficiency of patients with coronavirus (COVID-19)
COVID-19 patients Design: Patients will be recruited in the study through a convenient sampling (...) . Participants/Inclusion and exclusion criteria: Inclusion criteria: Aged18 to 40 years; both genders; Post Covid-19 patients; Hemodynamically stable; Non-diabetic patients; Non- Hospitalized Patients. Exclusion
IRCTID: IRCT20191117045462N7
  1. The effect of 16 weeks of concurrent home-based exercise on some physiological, psychological, functional, and anthropometric indices in females with breast cancer during the COVID-19 pandemic
  2. The effect of order of combined training (resistance and endurance) on health related quality of life in older women
  3. Effect of Plyometric Exercises on Improving Cardiorespiratory Endurance , Muscle Strength and Quality of life in Undergraduate Students
  4. The effect of home base exercise versus supervised exercise therapy on weight loss, fitness and muscle mass in patients undergoing Bariatric surgery
  5. Comparison of the metabolic factors in obese patients’ pre and post bariatric surgery after 3 months trial of aerobic versus strengthening exercises
  6. Effectiveness of lower limb strength training and aerobic exercises in combination with lifestyle modification on strength, aerobic fitness and quality of life in patients with type II diabetes mellitus.
  7. Clinical Trail of effect of exercise (resistance-core stability) on muscle strength, balance and core stability in women with breast cancer and healthy women
  8. Comparing of the Effect of Supportive Educative Program with Routine educative program on Stress, Anxiety, Depression and Satisfaction of Patients With COVID-19 Admitted to COVID units
  9. The Effect of Functional Electrical Stimulation Intervention on Fatigue, Muscle Strength, Muscle Mass and Quality of Life in Older Adults with COVID-19
  10. Evaluation effects of multimodal rehabilitation on recovery of ICU Acquired weakness following coronavirus infection(COVID-19)
covid-19 Design: The double-blind, randomized, controlled trial study conducted on 50 diabetic patients with COVID-19. Randomization will be performed using a table of random numbers. Patients will be (...) obtaining written informed consent. Settings and conduct: Patients diagnosed with COVID-19 who are
IRCTID: IRCT20230523058271N1
  1. Investigating the effectiveness of pentoxifylline in diabetic patients with covid-19 : a clinical trial
  2. Investigation of the efficacy and safety of colchicine In combination with standard treatment on covid-19 patients: A clinical trial
  3. Effect of atorvastatin on mortality rate and symptom improvement in hospitalized patients with COVID-19
  4. Comparison of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen with Lopinavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19, A randomized, double-blind study
  5. Effect of Intravenous immunoglobulin (IVIG) versus Kaletra (lopinavir and ritonavir) tablets in patients with acute respiratory infection (COVID-19): A clinical trial studies
  6. Evaluation of the efficacy of the triple combination of interferon beta-1B (IFN β-1b), chloroquine and Kaletra in the treatment and improvement of symptoms in patients with covid -19: Clinical trial.
  7. Evaluation of the effect of herbal medicine containing Saatar, Hofarigon and Fennel on reduction of pulmonary complications of COVID-19 in patients: a clinical trial
  8. Comparison of the effectiveness and complication of dexamethasone at doses of 8 and 24 mg in the treatment of in Hospitalized Patients with Covid-19
  9. Evaluation of the efficacy and side effects of combination therapy of Kaletra and Hydroxychloroquine in comparison with Atazanavir / Ritonavir and Hydroxychloroquine in the treatment of patients with COVID-19
  10. ٍEvaluation of Safety and efficacy of anakinra utilization in COVID-19, a randomized controlled clinical trial
anxiety, depression, and distress of frontline nurses during the COVID-19 epidemic 2- Evaluation of the effectiveness of spirituality on psychological variables in frontline nurses during the COVID-19 epidemic (...) fact that the study was conducted during the COVID-19 epidemic, after obtaining written permission from
IRCTID: IRCT20091220002898N13
  1. Effect of Logotherapy Based on Rumi’s Thoughts on Symptoms of Anxiety and Depression in Nurses
  2. The Impact of Balint Group on Mental Health of Healthcare Workers in Covid-19 Pandemic
  3. The effectiveness of online mindfulness training based on stress reduction (MBSR) on mental health and quality of work life of nurses fighting on the frontlines against COVID-19
  4. Comparing the effectiveness of acceptance and commitment therapy and hope therapy based on a positive psychology approach on psychological well-being and improving the mental health of medical staff during the covid-19 epidemic
  5. The effectiveness of group Logotherapy on improving psychological symptoms and interpersonal emotion regulation in cardiovascular patients
  6. The Effectiveness of Transdiagnostic based Emotional efficacy on the Faulty Cognitive-affective system, Psychological syndrome and Sleep Quality of Nurses with Anxiety Signs
  7. Effect of Stress Management Program on Psychological Distress of Cancer Patients and Caring Burden and Quality of Life of Their Caregivers during the COVID-19 Epidemic
  8. Evaluation of the effectiveness of prenatal self-care training application in Covid 19 pandemic on quality of life, depression, corona anxiety and fear of childbirth in pregnant women
  9. The effect of online group support on psychological distress and self-care behaviors of the elderly with type 2 diabetes during the COVID-19 pandemic: a parallel randomized clinical trial
  10. The effectiveness of existential therapy on pathological worry and death anxiety of nurses who experienced sorrow due to the covid-19 pandemic
Study aim: To assess the effect of prone and orthopnea positions versus supine position on comfort, dyspnea and arterial blood oxygen saturation in patients with Covid-19 Design: This is a randomized (...) study. Participants/Inclusion and exclusion criteria: Inclusion criteria: Age 18 to 60 years; Covid-19
IRCTID: IRCT20120215009014N425
COVID-19 Design: Randomized controlled trial parallel with control group Settings and conduct: This (...) recovered from Covid-19 patients. Sampling is done in hospitals affiliated to Kashan University of Medical (...) - having literacy Exclusion criteria 1- reinfection to COVID-19 during the study 2- Starting the medical
IRCTID: IRCT20130721014086N16
oxygen saturation, it can be used as an effective drug in covid 19. (...) 19. Design: Data are collected in two groups of intervention and control and will be analyzed by (...) positive Covid will participate in the study. To blind a colleague, another doctor will be in charge of
IRCTID: IRCT20210517051326N1
depression in the elderly with COVID- 19 admitted to Firoozabadi Hospital in Rey Design: Non-randomized (...) : Age over 60 years based on patient record , patient with COVID-19 on first day of hospitalization (...) according to information ,previous history of hospitalization due to COVID- 19 disease, use of barbiturates
IRCTID: IRCT20220609055119N1
  1. The effect of supportive nursing program on depression anxiety and stress of family member of patient during coronary artery bypass surgery
  2. The effect of online group support on psychological distress and self-care behaviors of the elderly with type 2 diabetes during the COVID-19 pandemic: a parallel randomized clinical trial
  3. Comparing of the Effect of Supportive Educative Program with Routine educative program on Stress, Anxiety, Depression and Satisfaction of Patients With COVID-19 Admitted to COVID units
  4. Evaluation of the effect of scheduled online video meeting on anxiety, stress and depression of patients admitted with Quaid 19
  5. The effect of educational intervention based on social support theory on the reduction of stress related to COVID-19 in diabetic patients
  6. The design plan of Comprehensive Group-Based Spiritual well-being) and effect on Emotional-Cognitive Regulation (ECR) in elders living in elderly day care home of Shahr-e-Kord
  7. The effect of family support programs on depression, anxiety, stress and satisfaction of family caregiver`s in patients' open heart surgery.
  8. The effect of multimedia-based peer support groups on anxiety in patients with COVID-19: a parallel randomized clinical trial
  9. Effect of medical team supportive intervention through social networks on health anxiety and acceptance of disability in patients with systemic lupus erythematosus referred to selected educational and medical centers affiliated to Shiraz University of Medical Sciences-2020
  10. The Effect of spiritual Counseling base on spiritual intelligence on depression, Anxiety and stress of pregnant Women
Study aim: Evaluation of the effect of subcutaneous adalimumab on the prognosis of patients with COVID-19 Design: Clinical trial with parallel control group with parallel, non-blind, non-randomized (...) criteria: patients suffering severe COVID-19; patient consent; age 60_70 years old. Exclusion criteria
IRCTID: IRCT20220112053701N1
  1. Evaluation of adalimumab effect on clinical symptoms including respiratory distress, oxygen saturation and lung involvement of patients with COVID-19
  2. A Phase III, randomized, two-armed, double-blind (patient and assessor blinded), parallel active controlled non-Inferiority clinical trial to determine the non-inferior therapeutic efficacy and safety of two disease-modifying anti rheumatic drugs (CinnoRA ) versus Humira® for treatment of Active rheumatoid arthritis
  3. Evaluating the efficacy and safety of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19
  4. Comparison of Effectiveness of Remdesivir with Remdesivir and Interferon Beta-1 a Treatment Regime on Clinical Outcome of Covid 19 Patients
  5. Evaluation of the efficacy and safety of Adalimumab and methylprednisolone pulse therapy in treatment of Covid-19 patients with ARDS
  6. Evaluation of effectiveness and safety of Doxycycline in combination with standard treatment on clinical improvement and outcome of Covid-19 patients: a clinical trial
  7. Impact of vitamin B, A, D, E, C supplementation on improvement and mortality rate in patients with COVID-19 admitted in intensive care unit
  8. The effect of atorvastatin on on inflammatory factors and prognosis outcomes in patients with Covid 19, hospitalized in Hajar Hospital, Shahrekord University of Medical Sciences, 2021
  9. The effect of vitamin A, B, C, D, and E supplementations on biochemical parameters of critically ill patients with COVID-19: A randomized clinical trial
  10. Atorvastatin effect in Clinical and Laboratory findings of patiens with COVID-19 admitted RAZI referral hospital in Mazandaran State: A Randomized Clinical Trial
to Covid-19 who have/have not received Antibiotics Design: This is a clinical trial study with (...) : 70 patients with suspected Covid 19 will be selected. Patients are between 2 and 14 years old. Then (...) : Patients suspected of having Covid 19 with approved molecular test admitted to Hajar Hospital in Shahrekord
IRCTID: IRCT20220116053739N1
Study aim: Determining the effect of visual communication with family on anxiety of death of elderly patients with Covid 19 hospitalized in corona wards of Imam Khomeini Hospital in Esfarayen Design (...) sample in this study will include elderly patients with Covid 19 admitted to Imam Khomeini Hospital in
IRCTID: IRCT20220122053782N1
between Covid-19 patients receiving remdesivir with and without simultaneous acetylcysteine therapy 2. To compare the incidence of acute liver injury between Covid-19 patients receiving remdesivir with (...) aged above 18 years admitted in intensive care unit with definite diagnosis of Covid-19 under treatment
IRCTID: IRCT20210726051995N1
Loading...